Compare Hims and Hers Health Inc (HIMS) vs Omnicom Group Inc. (OMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Omnicom Group Inc. — how do they compare? Hims and Hers Health Inc trades at $32.79 (market cap $7.57B), while Omnicom Group Inc. trades at $82.4 (market cap $23.48B). The key difference: Omnicom Group Inc. is far larger — about 3.1× Hims and Hers Health Inc's market cap, and Omnicom Group Inc. pays a 3.88% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| HIMS | OMC | |
|---|---|---|
Market Cap | $7.57B | $23.48B |
Sector | Health | Media |
52-Week High | $66.18 | $85.80 |
52-Week Low | $14.52 | $67.27 |
Enterprise Value | $7.95B | $30.70B |
Dividend Yield | — | 3.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.
The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.
Omnicom (OMC) trades at $82.36, up 0.77% with a bullish technical outlook and strong cash flow generation. The stock shows attractive valuation metrics with a P/E of 12.16 and P/S of 0.95, though 2025 saw a net loss of $54.5 million despite revenue growth to $17.27 billion. Recent developments include major client wins with IBM and Netflix partnerships, positioning the company for future growth in digital advertising.
OMC presents a compelling value opportunity with 28% upside to the $105.75 consensus price target, supported by dividend payments and institutional confidence. Key risks include intense industry competition and the need to sustain profitability improvements after the 2025 loss. The upcoming Q2 2026 earnings report on July 28 will be critical for validating the company's turnaround trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Omnicom Group Inc.
Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →
